Advertisement NextBio Signs License Agreement With UCB - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

NextBio Signs License Agreement With UCB

NextBio, a developer of software platform that enables life science researchers to search, discover and share knowledge locked within public and proprietary data, has signed a license agreement with UCB for NextBio Enterprise.

NextBio Enterprise offers life sciences organisations tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.

Saeid Akhtari, co-founder and CEO of NextBio, said: “UCB is one of the biopharmaceutical companies, with operations in Europe, the US and Asia. We are very pleased that they are adopting the Enterprise version of the NextBio platform as an integral part of their research and development efforts.

“UCB’s adoption of NextBio Enterprise will enable its scientists to gain unique insights from data created by diverse high-throughput technologies.”